4541.T实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (28 Mar 2023 @ 14:15):

Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, imports, and distributes various pharmaceutical products. The company operates through two segments, Sagent Group and Nichi-Iko Group...

Stats
今日成交量	5.21M
平均成交量	4.06M
市值	2.47B
EPS	¥0 ( 2023-05-11 )
Last Dividend	¥10.00 ( 2022-03-30 )
Next Dividend	¥0 ( N/A )
P/E	0.0000000
ATR14	¥4.97 (0.00%)

音量相关性

長: -0.06 (neutral)

短: -0.73 (moderate negative)

Signal:(100) Neutral

Nichi-Iko Pharmaceutical 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Nichi-Iko Pharmaceutical 相关性 - 货币/商品

0.08
( neutral )

-0.08
( neutral )

0.11
( neutral )

0.21
( neutral )

-0.13
( neutral )

Nichi-Iko Pharmaceutical 财务报表

Annual	2022
营收:	¥16 907.73B
毛利润:	¥3 331.59B (19.70 %)
EPS:	¥128.01

FY	2022
营收:	¥16 907.73B
毛利润:	¥3 331.59B (19.70 %)
EPS:	¥128.01

FY	2022
营收:	¥179.06B
毛利润:	¥3.97B (2.21 %)
EPS:	¥-1 500.00

FY	2021
营收:	¥188.22B
毛利润:	¥21.25B (11.29 %)
EPS:	¥-65.28

Financial Reports:

No articles found.

Nichi-Iko Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Nichi-Iko Pharmaceutical Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.48 - good (94.76%) | Divividend Growth Potential Score: 2.03 - No dividend growth expected in the near future

Information

First Dividend	¥12.00	2008-05-27
Last Dividend	¥10.00	2022-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	29	--
Total Paid Out	¥380.90	--
Avg. Dividend % Per Year	0.00%	--
Score	3.02	--
Div. Sustainability Score	9.48
Div.Growth Potential Score	2.03
Div. Directional Score	5.75	--

Next Divdend (Est)
(2024-06-10)

¥0 Estimate 0.00 %

Dividend Stability

0.10 Very Bad

Dividend Score

3.02

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8058.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7315.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6564.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
5915.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4578.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
3834.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3085.T	Ex Dividend Knight	2023-06-29	Semi-Annually	0.00%
1951.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
9948.T	Ex Dividend Knight	2024-02-28	Semi-Annually	0.00%
8957.T	Ex Dividend Knight	2024-01-30	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0400	1.500	9.20	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0137	1.200	9.54	10.00	[0 - 0.3]
returnOnEquityTTM	0.0717	1.500	-0.315	-0.472	[0.1 - 1]
payoutRatioTTM	0.555	-1.000	4.45	-4.45	[0 - 1]
currentRatioTTM	1.440	0.800	7.80	6.24	[1 - 3]
quickRatioTTM	0.617	0.800	-1.074	-0.859	[0.8 - 2.5]
cashRatioTTM	0.584	1.500	7.86	10.00	[0.2 - 2]
debtRatioTTM	0.185	-1.500	6.92	-10.00	[0 - 0.6]
interestCoverageTTM	92.82	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	119.18	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	86.82	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.474	-1.500	8.11	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.202	1.000	9.97	9.97	[0.2 - 0.8]
operatingProfitMarginTTM	0.0414	1.000	-1.172	-1.172	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.121	1.000	-0.438	-0.438	[0.2 - 2]
assetTurnoverTTM	0.344	0.800	-1.042	-0.833	[0.5 - 2]
Total Score				9.48

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	0.478	1.000	-0.0527	0	[1 - 100]
returnOnEquityTTM	0.0717	2.50	-0.202	-0.472	[0.1 - 1.5]
freeCashFlowPerShareTTM	86.82	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	119.18	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0.555	1.500	4.45	-4.45	[0 - 1]
pegRatioTTM	0.00441	1.500	-3.30	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0651	1.000	-0.872	0	[0.1 - 0.5]
Total Score				2.03

Nichi-Iko Pharmaceutical

Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, imports, and distributes various pharmaceutical products. The company operates through two segments, Sagent Group and Nichi-Iko Group. It primarily focuses on the production of generic drugs. The company offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin ? antagonist, angiotensin ? antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products. It also provides treatments for circulatory, digestive, respiratory, central and peripheral nervous systems, and others. In addition, the company engages in the packaging design business. Further, it exports its products. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was incorporated in 1947 and is headquartered in Toyama, Japan.